We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NVCR market cap is 1.28B. The company's latest EPS is USD -1.9333 and P/E is -6.38.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 131M | 128.43M | 122.18M | 126.05M | 127.32M |
| Operating Income | -24.75M | -44.03M | -60.38M | -61.75M | -56.85M |
| Net Income | -26.58M | -37.3M | -53.06M | -57.42M | -49.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 351.32M | 494.37M | 535.03M | 537.84M | 509.34M |
| Operating Income | -1.83M | 30.4M | -44.33M | -89.52M | -232.87M |
| Net Income | -7.23M | 19.81M | -58.35M | -92.53M | -207.04M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.17B | 1.19B | 1.17B | 1.16B | 1.15B |
| Total Liabilities | 728.81M | 750.48M | 742.19M | 743.33M | 752.65M |
| Total Equity | 445.4M | 441.17M | 432.15M | 415.68M | 393.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 479.45M | 1.05B | 1.14B | 1.19B | 1.15B |
| Total Liabilities | 261.66M | 575.46M | 729M | 750.48M | 783.63M |
| Total Equity | 217.79M | 476.53M | 410.49M | 441.17M | 362.5M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 34.5M | 30.79M | -16.73M | -39.46M | -58.78M |
| Investing | -11.9M | -139.96M | 82.29M | 68.39M | 85.65M |
| Financing | 12.08M | 15.49M | 5.2M | 12.71M | 13.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 26.62M | 99.15M | 82.76M | 30.79M | -73.34M |
| Investing | -51.67M | -472.85M | -144.83M | -139.96M | 184.15M |
| Financing | 61.68M | 440.21M | 25.7M | 15.49M | 15.79M |
| Market Cap | 1.28B |
| Price to Earnings Ratio | -6.38 |
| Price to Sales Ratio | 2.59 |
| Price to Cash Ratio | 5.49 |
| Price to Book Ratio | 3.65 |
| Dividend Yield | - |
| Shares Outstanding | 107.09M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.23M |
| 52 Week Change | -80.74% |
| 52 Week High | 83.60 |
| 52 Week Low | 10.87 |
| Spread (Intraday) | 0.03 (0.25%) |
| Company Name | NovoCure Ltd |
| Address |
no 4 the forum jersey JE2 4UF |
| Website | https://www.novocure.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
